These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8591068)

  • 1. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.
    Lavezo LA; Davis RL
    J Spinal Cord Med; 1995 Oct; 18(4):233-5. PubMed ID: 8591068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
    Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
    Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the predictive ability of the "spinal cord injury equation" in estimating vancomycin clearance.
    Lee JP; Wang YJ
    Am J Health Syst Pharm; 2013 Apr; 70(8):669-74. PubMed ID: 23552044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for administering vancomycin in the spinal cord injured population.
    Griver AR; Prince RA; Darouiche RO
    Arch Phys Med Rehabil; 1997 May; 78(5):459-62. PubMed ID: 9161361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in vancomycin pharmacokinetics in critically ill infants.
    Gous AG; Dance MD; Lipman J; Luyt DK; Mathivha R; Scribante J
    Anaesth Intensive Care; 1995 Dec; 23(6):678-82. PubMed ID: 8669599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in vancomycin pharmacokinetics during treatment.
    Pou L; Rosell M; Lopez R; Pascual C
    Ther Drug Monit; 1996 Apr; 18(2):149-53. PubMed ID: 8721277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
    Morbitzer KA; Jordan JD; Sullivan KA; Durr EA; Olm-Shipman CM; Rhoney DH
    Neurocrit Care; 2016 Oct; 25(2):250-7. PubMed ID: 26942732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?
    DeCarolis DD; Thorson JG; Marraffa RA; Clairmont MA; Kuskowski MA
    Ther Drug Monit; 2014 Oct; 36(5):632-9. PubMed ID: 25222855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
    Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
    Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.
    Ducharme MP; Slaughter RL; Edwards DJ
    Ther Drug Monit; 1994 Oct; 16(5):513-8. PubMed ID: 7846752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting serum levels of adiponectin, ghrelin, and leptin in men with spinal cord injury.
    Wang YH; Huang TS; Liang HW; Su TC; Chen SY; Wang TD
    Arch Phys Med Rehabil; 2005 Oct; 86(10):1964-8. PubMed ID: 16213239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
    Wragge TM; Cooper BE
    Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
    Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
    Marqués-Miñana MR; Saadeddin A; Peris JE
    Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.